Form 4: Phio Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Ronald Todd Plott, a Director of Phio Pharmaceuticals Corp., received 17,000 shares of common stock on September 28, 2026.
Summary
- Grant/award: acquired 17,000 Common Stock, $.0001 par value on September 28, 2026; holds 32,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ronald Todd Plott — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Grant/award | Common Stock, $.0001 par value | 17,000 | — | — | 32,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Grant/award (17,000 shares) |
Keywords
insider transaction, Form 4, PHIO, Phio Pharmaceuticals Corp., neutral, Ronald Todd Plott
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.